IFNA1 and cancer: The capability of IFN-DCs to migrate toward the chambers filled with cancer cells rather than matrix alone was evaluated over a period of 24 to 48 h by wide-field imaging analysis of the entire microfluidic device, and the total number of IFN-DCs within the micro-channels and tumor-chambers was quantified.